Todays milestone expands the strong clinical profile of Wegovy that includes multiple indications that no other GLP-1 for weight loss can claim. As with other drugs in the same class, Wegovy HD comes with a familiar list of potential side effects including nausea, vomiting, constipation, fatigue, dizziness, headache, sensitivity to touch and hair loss
[Published online July 9, 2025] European Medicines Agency
207 Liraglutide treatment was also demonstrated to inhibit beta-cell apoptosis in isolated human pancreatic beta-cells, and after 24 hours, the islet beta-cell proliferation rate tripled
Researchers highlight risks between 14% and 36% higher compared to drugs like DPP-4 inhibitors or sulfonylureas
Within two months, hed gone from 186 to 166 pounds
That might sound minor, but even modest reductions can move the needle on cardiovascular riskespecially over years